ArticleBMC endocrine disorders2026
Novel association between atherogenic index of plasma and bone mineral density in men: a retrospective analysis.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to investigate the association between the atherogenic index of plasma (AIP), lipid parameters, and bone mineral density (BMD) in men with osteoporosis.
methodsThis retrospective, single-center study included 430 male patients aged ≥ 50 years admitted to the First Hospital of Shanxi Medical University between June 2022 and December 2024. Routine blood lipid profiles, including total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL) were collected. AIP was calculated as log10(TG/HDL). BMD was measured using dual-energy X-ray absorptiometry (DXA) and patients were categorized into normal (NO), osteopenia (ON), and osteoporosis (OP) groups. Correlation analysis, principal component analysis (PCA), and one-way Analysis of Variance (ANOVA) were applied.
resultsAmong 430 participants, 218 were classified as NO, 133 as ON, and 79 as OP. PCA revealed that the first two components (PC1 eigenvalue = 2.127, PC2 eigenvalue = 1.531) explained 73.15% of the total variance (PC1: 42.53%, PC2: 30.62%), with AIP and TC identified as major contributors to BMD variation. Correlation analysis showed that AIP (r = -0.26,p = 0.003), TG (r = -0.15,p = 0.047), and HDL (r = 0.34,p < 0.001) were significantly associated with BMD, while TC and LDL were not. ANOVA demonstrated significant group differences in AIP and HDL, particularly between the OP and NO groups.
conclusionElevated AIP and altered HDL levels are associated with reduced BMD in men, highlighting their potential role in the early identification and risk stratification of male osteoporosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.